Citeline, a company that provides intelligence solutions for the life sciences industry, has launched two new AI-powered tools called Protocol SmartDesign and Investigator SmartSelect. These tools aim to make clinical trial development faster and more efficient.
What Protocol SmartDesign Does
Protocol SmartDesign uses AI and machine learning to analyze large amounts of data, including clinical trial information and patient details. This helps researchers make better decisions about how to design trials, choose goals, and decide who can participate. The tool also uses past data to predict how long a trial might take and how many people will join.
How Investigator SmartSelect Helps
Investigator SmartSelect makes it easier to find and choose qualified investigators for clinical trials. By combining AI with Citeline’s large database of investigators, the tool quickly creates a list of potential sites and investigators that meet the trial’s needs. This saves time and effort, allowing researchers to focus on other important parts of the trial.
Both tools are designed to reduce the chances of costly changes to trial plans, which can delay timelines and increase budgets. By optimizing trial design and investigator selection, Citeline’s solutions help avoid these issues. Maureen Ladouceur, RN, president of Norstella, Citeline’s parent company, said these tools save time and money for medical teams and ease the workload for study teams and site staff.
Source: hitconsultant
